BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
116 hedge funds and large institutions have $1.06B invested in BELLUS Health Inc. in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 12 closing their positions.
310% more call options, than puts
Call options by funds: $2.15M | Put options by funds: $524K
183% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 12
46% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 28
26% more capital invested
Capital invested by funds: $845M → $1.06B (+$219M)
23% more funds holding
Funds holding: 94 → 116 (+22)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$50.1M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$46.9M |
| 3 |
O
OrbiMed
New York
|
+$33.8M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCOC
Power Corp of Canada
Montreal, Quebec,
Canada
|
-$45.6M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$39.5M |
| 3 |
AG
Artal Group
Luxembourg
|
-$10.6M |
| 4 |
TLP
Tri Locum Partners
New York
|
-$9.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.63M |
BLU Hedge Fund Activity: Q3 2022 in Review
116 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q3 2022, worth a combined $1.06B — up 26% from $845M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new BLU positions and 12 closed out — a net gain of 22 holders — while 41 added to existing stakes and 28 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $50.1M. The largest seller was Power Corp of Canada, exiting entirely with an estimated $45.6M sold.
- 116 institutional investors held BELLUS Health Inc. (BLU) as of Q3 2022, up from 94 in Q2 2022.
- Funds reported $1.06B of BELLUS Health Inc. stock for Q3 2022, up 26% quarter-over-quarter.
- 34 funds opened new BELLUS Health Inc. positions in Q3 2022 and 12 closed out, a net change of +22 holders.
- The largest BELLUS Health Inc. buyer in Q3 2022 was Perceptive Advisors, an estimated $50.1M added.
- The largest BELLUS Health Inc. seller in Q3 2022 was Power Corp of Canada, an estimated $45.6M sold.
Based on aggregated 13F filings for Q3 2022.